Tetraphase Pharmaceuticals, Inc. (TTPH) Posts Mixed Q1 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts TTPH Hot Sheet
Join SI Premium – FREE
Tetraph Pharma (NASDAQ: TTPH) reported Q1 EPS of ($0.30), $0.03 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $2.49 million.
For earnings history and earnings-related data on Tetraph Pharma (TTPH) click here.
For earnings history and earnings-related data on Tetraph Pharma (TTPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennox (LII) Misses Q3 EPS by 52c, Beats on Revenue; Offers FY26 EPS Guidance
- TE Connectivity (TEL) Tops Q4 EPS by 7c, Beats on Revenue; Offers Q1 Guidance
- Biogen (BIIB) Tops Q3 EPS by 60c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
